Botox injections studied for movement disorder relief

NCT ID NCT00001208

Recruiting now Disease control Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 7 times

Summary

This study uses botulinum toxin (Botox) injections to treat movement disorders such as dystonia, tremor, and spasticity. Up to 2,000 participants aged 2 and older will receive tailored injections, with doctors trained in proper techniques. The goal is to manage symptoms and build a patient group for future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: botulinum toxin (Botox) injection
What this could lead to: If successful, this could improve symptom control for people with movement disorders and help train doctors in best injection techniques.
What could go wrong: This is an ongoing training and observation study, not a formal test of a new treatment. Results may not apply to all patients, and botulinum toxin can cause temporary muscle weakness or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEPHAROSPASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign essential blepharospasm clonic hemifacial spasm dystonic disorder movement disorder spasmodic dystonia tardive dyskinesia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MOVEMENT DISORDERS

Contacts and locations

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.